Journals / Türk Toraks Dergisi / 2008 / Cilt: 9 - Sayı: 4

Allergic bronchopulmonary aspergillosis in patients with moderate and severe asthma

Orta ve ağır astımlı olgularda alerjik bronkopulmoner aspergilloz

Pages
151–156
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, ABPA should be considered in patients with poorly controlled severe asthma

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Allergic bronchopulmonary aspergillosis (ABPA), which is predominantly a disease of severe asthmatic patients, is caused by hypersensitivity to aspergillus antigens.
📊
Key Findings & Data:Material and Method: In this study, we aimed to evaluate the prevalence of ABPA in patients with moderate and severe asthma.
💡
Conclusion & Impact:Therefore, ABPA should be considered in patients with poorly controlled severe asthma
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Deri testleri · Solunum aşırı duyarlılığı · Radyoallergosorbent testi

Abstract

Introduction: Allergic bronchopulmonary aspergillosis (ABPA), which is predominantly a disease of severe asthmatic patients, is caused by hypersensitivity to aspergillus antigens. The prevalence of ABPA is speculative, as the few studies that were performed adopted widely different diagnostic criteria. Material and Method: In this study, we aimed to evaluate the prevalence of ABPA in patients with moderate and severe asthma. ABPA-Central bronchiectasis (ABPA-SB) was diagnosed if a patient had asthma, central bronchiectasis, positive Aspergillus fumigatus skin test or positive serum aspergillus sIgE. ABPA-Seropositive (ABPA-S) was diagnosed if a patient had asthma, elevated total IgE level, positive Aspergillus fumigatus skin test and positive serum aspergillus sIgE. Results: Of the sixty four patients, 71.9% had moderate asthma and 28.2% severe asthma. Positive Aspergillus sIgE was present in 2 patients (3.1%). Sensitivity to A. fumigatus with skin test was shown in a total of 4 (7.8%) patients. Central bronchiectasis was seen on HRCT in seven of the patients (14.6%) and central mucus impaction was seen in one patient (2%). In this study, ABPA was diagnosed in 2 (3.1%) patients. Two (3.1%) patients were evaluated as aspergillus-sensitive asthma. Conclusion: Patients with ABPA had severe asthma. Therefore, ABPA should be considered in patients with poorly controlled severe asthma

Özet

Giriş: Allerjik bronkopulmoner aspergilloz (ABPA), ağır astımlı olgularda görülmektedir ve aspergillus antijenlerine aşırı duyarlılık nedeni ile oluşmaktadır. ABPA sıklığına dair bilgiler, farklı tanısal kriterlerin kullanıldığı az sayıda çalışma nedeniyle tahmine dayalıdır. Gereç ve Yöntem: Bu çalışmada; orta ve ağır persistan astımlı olgularda ABPA sıklığı araştırılmıştır. ABPA-Santral bronşektazi (ABPA-SB) tanısı; astım, santral bronşektazi, Aspergillus fumigatus deri testi pozitifliği veya serumda aspergillus sIgE pozitifliği; ABPA-Seropozitif (ABPA-S) tanısı; astım, yüksek total IgE düzeyi, Aspergillus fumigatus deri testi pozitifliği ve serumda aspergillus sIgE saptanması ile konmuştur. Bulgular: Altmış dört olgunun %71.9'u orta, %28.2'si ağır persistan astımdır. Aspergillus sIgE, 2 (%3.1) olguda pozitiftir. Deri testlerinde A. fumigatus pozitifliği toplam 4 olguda (%7.8) gösterilmiştir. YRBT ile 7 (%14.6) olguda santral bronşektazi ve 1 (%2) olguda santral yerleşimli mukus tıkacı saptanmıştır. Çalışmamızda 2 (%3.1) olgu ABPA-SB tanısı almıştır. İki (%3.1) olgu ise aspergillus duyarlı astım olarak değerlendirilmiştir. Sonuç: ABPA'lı olgular, ağır persistan astımlı olgulardır. Bu nedenle kontrolü güç ağır astım olgularında ABPA düşünülmelidir.

🔖

Cite This Article

AYDOĞAN, Ö., ERDİNÇ, M., AYTEMUR, Z. A., SİN, A., SAVAŞ, R. (2008). Allergic bronchopulmonary aspergillosis in patients with moderate and severe asthma. Türk Toraks Dergisi, Cilt: 9 - Sayı: 4, 151–156. https://ajindex.com/articles/329597

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Maurya V, Gugnani HC. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005;127:1252-9
  2. Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-14
  3. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92
  4. Vlahakis N, Aksamit T. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001;76:930-8
  5. Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol 2000;18:181-5
  6. Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002;325:411-4
  7. Kauffman HF, van der Heide S. Exposure, sensitisation, and mechanisms of fungus-induced asthma. Curr Allergy Asthma Rep 2003;3:430-7
  8. Türk Toraks Derneği Ulusal Astım Tanı ve Tedavi Rehberi. 1. baskı. Ankara: Turgut Yayıncılık ve Tic A.Ş., 2000
  9. Mungan D. Alerji Deri Testleri. In: Mirici A, Yıldız F; eds. Göğüs Hastalıklarında Tanı Yöntemleri. 1. baskı. Ankara: Turgut Yayıncılık ve Ticaret A.Ş., 2003:194-204
  10. Denning DW, O'Driscoll BR. The link between fungi and severe asthma: a summary of evidence. Eur Respir J 2006;27:615-26
  11. Miles J, Clayton R, Ayres J. Atopic status in patients with brittle and non brittle asthma: a case-control study. Clin Exp Allergy 1995;25:1074-82
  12. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000;55:501-4
  13. Kheradmand F, Kiss A, Xu J, et al. A protease-activated pathway underlying Th cell type 2 activation and allergic disease. J Immunol 2002;169:5904-11
  14. Kauffman HF, Tomee JF, van de Riet MA, et al. Protease dependent activation of epithelial ceel by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185-93
  15. Nigam S, Grosh PC, Sarma PU. A new glycoprotein allergen/antigen with the protease activity from Aspergillus fumigatus. Int Arch Allergy Immunol 2003;132:124-31
  16. Green BJ, Sercombe JK, Tovey ER. Fungal fragments and undocumented conidia function as new aeroallergen source. J Allergy Clin Immunol 2005;115:1043-48
  17. Kauffman HF, Tomee JF, van der Werf TS, et al. Review of